54 related articles for article (PubMed ID: 38720336)
1. An On-Treatment Decreased Trend of Serum IL-6 and IL-8 as Predictive Markers Quickly Reflects Short-Term Efficacy of PD-1 Blockade Immunochemotherapy in Patients with Advanced Gastric Cancer.
Liu J; Mao Y; Mao C; Wang D; Dong L; Zhu W
J Immunol Res; 2024; 2024():3604935. PubMed ID: 38774604
[TBL] [Abstract][Full Text] [Related]
2. Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer.
Liu Y; Chen W; Ruan R; Zhang Z; Wang Z; Guan T; Lin Q; Tang W; Deng J; Wang Z; Li G
J Transl Med; 2024 May; 22(1):438. PubMed ID: 38720336
[TBL] [Abstract][Full Text] [Related]
3. Peeling the I-Onion to Demystify Pseudoprogression.
Tsang ES; Siu LL
Cancer Cell; 2023 Sep; 41(9):1545-1547. PubMed ID: 37699332
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial.
Tian Y; Yang P; Guo H; Liu Y; Zhang Z; Ding P; Zheng T; Deng H; Ma W; Li Y; Fan L; Zhang Z; Wang D; Zhao X; Tan B; Liu Y; Zhao Q
Int J Surg; 2023 Dec; 109(12):4000-4008. PubMed ID: 37678277
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients.
Yu JH; Xiao BY; Tang JH; Li DD; Wang F; Ding Y; Han K; Kong LH; Ling YH; Mei WJ; Hong ZG; Liao LE; Yang WJ; Pan ZZ; Zhang XS; Jiang W; Ding PR
Eur J Cancer; 2023 Oct; 192():113253. PubMed ID: 37625240
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.
Chen J; Liu K; Luo Y; Kang M; Wang J; Chen G; Qi J; Wu W; Wang B; Han Y; Shi L; Wang K; Han X; Ma X; Liu W; Ding Y; Wang L; Liang H; Wang L; Chen J
Gastroenterology; 2023 Jul; 165(1):88-103. PubMed ID: 36921674
[TBL] [Abstract][Full Text] [Related]
7. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J; Rugo HS; Cescon DW; Im SA; Yusof MM; Gallardo C; Lipatov O; Barrios CH; Perez-Garcia J; Iwata H; Masuda N; Torregroza Otero M; Gokmen E; Loi S; Guo Z; Zhou X; Karantza V; Pan W; Schmid P;
N Engl J Med; 2022 Jul; 387(3):217-226. PubMed ID: 35857659
[TBL] [Abstract][Full Text] [Related]
8. Lymph Node Metastasis Prediction From Whole Slide Images With Transformer-Guided Multiinstance Learning and Knowledge Transfer.
Wang Z; Yu L; Ding X; Liao X; Wang L
IEEE Trans Med Imaging; 2022 Oct; 41(10):2777-2787. PubMed ID: 35486559
[TBL] [Abstract][Full Text] [Related]
9. Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images.
Cheng N; Ren Y; Zhou J; Zhang Y; Wang D; Zhang X; Chen B; Liu F; Lv J; Cao Q; Chen S; Du H; Hui D; Weng Z; Liang Q; Su B; Tang L; Han L; Chen J; Shao C
Gastroenterology; 2022 Jun; 162(7):1948-1961.e7. PubMed ID: 35202643
[TBL] [Abstract][Full Text] [Related]
10. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Fanta P; Farjah F; Gerdes H; Gibson MK; Hochwald S; Hofstetter WL; Ilson DH; Keswani RN; Kim S; Kleinberg LR; Klempner SJ; Lacy J; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Outlaw D; Park H; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian N; Pluchino LA
J Natl Compr Canc Netw; 2022 Feb; 20(2):167-192. PubMed ID: 35130500
[TBL] [Abstract][Full Text] [Related]
11. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
[TBL] [Abstract][Full Text] [Related]
12. Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer.
Li F; Yang Y; Wei Y; He P; Chen J; Zheng Z; Bu H
J Transl Med; 2021 Aug; 19(1):348. PubMed ID: 34399795
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.
Qiu H; Cao S; Xu R
Cancer Commun (Lond); 2021 Oct; 41(10):1037-1048. PubMed ID: 34288593
[TBL] [Abstract][Full Text] [Related]
14. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Janjigian YY; Shitara K; Moehler M; Garrido M; Salman P; Shen L; Wyrwicz L; Yamaguchi K; Skoczylas T; Campos Bragagnoli A; Liu T; Schenker M; Yanez P; Tehfe M; Kowalyszyn R; Karamouzis MV; Bruges R; Zander T; Pazo-Cid R; Hitre E; Feeney K; Cleary JM; Poulart V; Cullen D; Lei M; Xiao H; Kondo K; Li M; Ajani JA
Lancet; 2021 Jul; 398(10294):27-40. PubMed ID: 34102137
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Alva AS; Mangat PK; Garrett-Mayer E; Halabi S; Hansra D; Calfa CJ; Khalil MF; Ahn ER; Cannon TL; Crilley P; Fisher JG; Haslem DS; Shrestha S; Antonelli KR; Butler NL; Warren SL; Rygiel AL; Ranasinghe S; Bruinooge SS; Schilsky RL
J Clin Oncol; 2021 Aug; 39(22):2443-2451. PubMed ID: 33844595
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
Chao J; Fuchs CS; Shitara K; Tabernero J; Muro K; Van Cutsem E; Bang YJ; De Vita F; Landers G; Yen CJ; Chau I; Elme A; Lee J; Özgüroglu M; Catenacci D; Yoon HH; Chen E; Adelberg D; Shih CS; Shah S; Bhagia P; Wainberg ZA
JAMA Oncol; 2021 Jun; 7(6):895-902. PubMed ID: 33792646
[TBL] [Abstract][Full Text] [Related]
17. Current treatment and recent progress in gastric cancer.
Joshi SS; Badgwell BD
CA Cancer J Clin; 2021 May; 71(3):264-279. PubMed ID: 33592120
[TBL] [Abstract][Full Text] [Related]
18. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]